What are the guidelines for the 3-hour glucose test in a pregnant woman with no prior history of gestational diabetes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Guidelines for the 3-Hour Glucose Tolerance Test in Pregnancy

The 3-hour, 100-gram oral glucose tolerance test (OGTT) is used as the second step in the two-step approach to diagnose gestational diabetes mellitus (GDM), and requires at least two of four elevated values (fasting, 1-hour, 2-hour, and 3-hour) to confirm the diagnosis. 1

When to Perform the 3-Hour Test

The 3-hour OGTT is indicated when:

  • A pregnant woman has a positive 50-gram, 1-hour glucose loading test (GLT) screening result at 24-28 weeks gestation 1
  • The screening threshold is ≥140 mg/dL (7.8 mmol/L), though ACOG recommends ≥135 mg/dL (7.5 mmol/L) in high-risk ethnic populations 1
  • Some experts use a lower threshold of ≥130 mg/dL (7.2 mmol/L) 1

Test Administration Protocol

The test must be performed after an overnight fast of at least 8 hours. 1

Blood glucose measurements are taken at four time points:

  • Fasting (before glucose administration)
  • 1 hour after 100-gram glucose load
  • 2 hours after glucose load
  • 3 hours after glucose load 1

Diagnostic Thresholds

GDM is diagnosed when at least two of the four values meet or exceed the following thresholds 1:

Carpenter/Coustan Criteria (Most Commonly Used):

  • Fasting: ≥95 mg/dL (5.3 mmol/L)
  • 1 hour: ≥180 mg/dL (10.0 mmol/L)
  • 2 hours: ≥155 mg/dL (8.6 mmol/L)
  • 3 hours: ≥140 mg/dL (7.8 mmol/L) 1

Alternative NDDG Criteria:

  • Fasting: ≥105 mg/dL (5.8 mmol/L)
  • 1 hour: ≥190 mg/dL (10.6 mmol/L)
  • 2 hours: ≥165 mg/dL (9.2 mmol/L)
  • 3 hours: ≥145 mg/dL (8.0 mmol/L) 1

Critical Clinical Considerations

A single abnormal value on the 3-hour test significantly increases risk for adverse outcomes. Women with only one elevated value have increased odds ratios for macrosomia (1.59), large-for-gestational-age infants (1.38), neonatal hypoglycemia (1.88), cesarean delivery (1.69), and pregnancy-induced hypertension (1.55) compared to women with normal results 2. These outcomes are comparable to women with diagnosed GDM 2.

ACOG now supports using a single elevated value for GDM diagnosis, recognizing the substantial risk associated with even one abnormal measurement 3, 4.

Two-Step vs. One-Step Approach Context

The two-step approach (which includes the 3-hour test) identifies approximately 5-6% of pregnant women with GDM, compared to 15-20% with the one-step 75-gram OGTT approach 1, 5. The two-step method has the advantage that the initial 50-gram screening does not require fasting, making it more convenient 1, 5.

Treatment of GDM diagnosed by the two-step approach reduces neonatal macrosomia, large-for-gestational-age births, and shoulder dystocia without increasing small-for-gestational-age births 1.

Post-Diagnosis Management

Once GDM is diagnosed:

  • Immediate nutritional counseling and lifestyle modification should begin 4, 6
  • Target glucose levels: fasting <95 mg/dL, 1-hour postprandial <140 mg/dL, 2-hour postprandial <120 mg/dL 4, 6
  • Insulin therapy should be initiated if targets are not met within 1-2 weeks of lifestyle modification 6
  • Approximately 70-85% of women achieve adequate control with lifestyle changes alone 4, 6

Postpartum Follow-Up

All women diagnosed with GDM must undergo a 75-gram OGTT at 4-12 weeks postpartum to assess for persistent diabetes 1, 4, 6. Women with a history of GDM have a 3.4-fold increased risk of developing type 2 diabetes and require lifelong screening at least every 3 years 4, 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnóstico de Diabetes Gestacional

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnosis and Management of Gestational Diabetes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

One-step or 2-step testing for gestational diabetes: which is better?

American journal of obstetrics and gynecology, 2021

Guideline

Treatment of Gestational Diabetes at 28 Weeks with Elevated 3-Hour GTT

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.